Research
Cellular
SGLT-2 inhibitors and GLP-1 receptor agonists demonstrate significant benefits beyond glucose control.
Practitioners should consider these medications for benefits beyond glycemic control.
StrongSupportsmedium confidence
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in particular have demonstrated significant benefits beyond glucose control.
Why this rating
The claim is supported by recent studies mentioned in the abstract.
Source
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?
Natasha P. Malkani et al. · Current Opinion in Endocrinology Diabetes and Obesity · 2022
DOI 10.1097/med.0000000000000787
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →